ENTPD1 and neoplasm: The ATP, released and accumulated from dead or damaged cells after targeted therapy or during unrestricted expansion of tumor tissue, is converted to adenosine by CD39 and CD73, which are expressed by tumor-associated cell components such as MDSCs, endothelial cells, and fibroblasts (41).